In both the Phase 1 and Phase 2 clinical trials no OCU410-related serious adverse events were observed and no cases of endophthalmitis, retinal detachment, vasculitis, choroidal neovascularization, or ...

An editorial published today in The New England Journal of Medicine (NEJM) writes that Science Corporation's PRIMA implant is the first treatment in clinical trials to successfully restore functional ...

The study found significant intra-group CMT reductions in the DEX-I group, with a higher percentage reduction than the ...

In this week’s Focus on Health, Dr. Robin Miller shares early research on a promising stem cell treatment for dry age-related ...

In advanced dry disease, a key problem is failure of retinal pigment epithelium, often shortened to RPE. These cells help ...

FREDERICK, MD, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Maryland Vision Institute (MVI) and Busack Eye ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

People with macular degeneration and other forms of central vision loss can see details like text and faces with this device.

Washington — The Kennedy Center's Board of Trustees voted to rename the performing arts institution the Trump-Kennedy Center, White House press secretary Karoline Leavitt said Thursday. "I have just ...

WASHINGTON — The President Trump-chaired board of the Kennedy Center voted Thursday to rename the marquee DC performance venue the “Trump-Kennedy Center” — delighting the president and dismaying his ...

This is read by an automated voice. Please report any issues or inconsistencies here. White House Press Secretary Karoline Leavitt said Thursday that the board of the John F. Kennedy Center for the ...

White House press secretary Karoline Leavitt announced Thursday that the Kennedy Center board voted unanimously to rename the building the Trump-Kennedy Center. “I have just been informed that the ...